A systematic review on quality of life (QoL) of patients with peritoneal metastasis (PM) who underwent pressurized intraperitoneal aerosol chemotherapy (PIPAC)

Autor: Li Zhenyue, Wong Louis Choon Kit, Sultana Rehena, Lim Hui Jun, Tan Joey Wee-Shan, Tan Qiu Xuan, Wong Jolene Si Min, Chia Claramae Shulyn, Ong Chin-Ann Johnny

Publikováno v: Pleura and Peritoneum, Vol 7, Iss 2, Pp 39-49 (2022)

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) has recently emerged as a palliative alternative for patients with unresectable peritoneal metastasis (PM). Quality of life (QoL) has increasingly been used as an endpoint to evaluate treatment

Externí odkaz: https://doaj.org/article/15234a30fd21477db0e8a1b03ffb77c6

Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal sarcomatosis—A systematic review and meta-analysis

Autor: Wong, Louis Choon Kit, Li, Zhenyue, Fan, Qiao, Tan, Joey Wee-Shan, Tan, Qiu Xuan, Wong, Jolene Si Min, Ong, Chin-Ann Johnny, Chia, Claramae Shulyn

Publikováno v: In European Journal of Surgical Oncology March 2022 48(3):640-648

Prospective Comparison of the Performance of MRI Versus CT in the Detection and Evaluation of Peritoneal Surface Malignancies.

Autor: Chia, Claramae Shulyn^1,2,3,4 (AUTHOR) claramae.chia.s.l@singhealth.com.sg, Wong, Louis Choon Kit^1,2,5 (AUTHOR) zhu.hong.yuan@nccs.com.sg, Hennedige, Tiffany Priyanthi⁶ (AUTHOR) hennedige.tiffany.priyanthi@singhealth.com.sg, Ong, Whee Sze⁷ (AUTHOR) ong.whee.sze@singhealth.com.sg, Zhu, Hong-Yuan^1,2 (AUTHOR) grace.tan.h.c@singhealth.com.sg, Tan, Grace Hwei Ching^1,2 (AUTHOR) seo.chin.jin@singhealth.com.sg, Kwek, Jin Wei⁶ (AUTHOR) kwek.jin.wei@singhealth.com.sg, Seo, Chin Jin^1,2 (AUTHOR) jolene.wong.s.m@singhealth.com.sg, Wong, Jolene Si Min^1,2,3,4 (AUTHOR) johnny.ong.c.a@singhealth.com.sg, Ong, Chin-Ann Johnny^1,2,3,4,8,9 (AUTHOR) soo.khee.chee@singhealth.com.sg, Thng, Choon Hua⁶ (AUTHOR) thng.choon.hua@singhealth.com.sg, Soo, Khee Chee^1,2,3,4 (AUTHOR) melissa.teo.c.c@singhealth.com.sg, Teo, Melissa Ching Ching^1,2,3,4 (AUTHOR)

Publikováno v: Cancers. Jul2022, Vol. 14 Issue 13, pN.PAG-N.PAG. 16p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A Systematic Review and Meta-Analysis of Mapping Biopsy for Primary Extramammary Paget's Disease in Reducing Recurrence Following Surgical Excision.

Autor: Murugan T; From the Division of Surgery and Surgical Oncology, Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), National Cancer Centre Singapore, Singapore.; Division of Surgery and Surgical Oncology, Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Singapore General Hospital, Singapore., Wong LCK; From the Division of Surgery and Surgical Oncology, Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), National Cancer Centre Singapore, Singapore.; Division of Surgery and Surgical Oncology, Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Singapore General Hospital, Singapore., Ong XS; From the Division of Surgery and Surgical Oncology, Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), National Cancer Centre Singapore, Singapore.; Division of Surgery and Surgical Oncology, Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Singapore General Hospital, Singapore., Tan SH; Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore., Tan JW; From the Division of Surgery and Surgical Oncology, Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), National Cancer Centre Singapore, Singapore.; Division of Surgery and Surgical Oncology, Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Singapore General Hospital, Singapore.; Laboratory of Applied Human Genetics, Division of Medical Sciences, National Cancer Centre Singapore, Singapore., Liu Y; From the Division of Surgery and Surgical Oncology, Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), National Cancer Centre Singapore, Singapore.; Division of Surgery and Surgical Oncology, Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Singapore General Hospital, Singapore.; Laboratory of Applied Human Genetics, Division of Medical Sciences, National Cancer Centre Singapore, Singapore., Shannon NB; From the Division of Surgery and Surgical Oncology, Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), National Cancer Centre Singapore, Singapore.; Division of Surgery and Surgical Oncology, Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Singapore General Hospital, Singapore.; Laboratory of Applied Human Genetics, Division of Medical Sciences, National Cancer Centre Singapore, Singapore., Chiang J; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Poon E; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Chan JY; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.; Cancer Discovery Hub, National Cancer Centre Singapore, Singapore., Yang VS; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.; Institute of Molecular and Cell Biology, A*STAR Research Entities, Singapore., Somasundaram N; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.; SingHealth Duke-NUS Oncology Academic Clinical Program, Duke NUS Medical School, Singapore., Farid M; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.; SingHealth Duke-NUS Oncology Academic Clinical Program, Duke NUS Medical School, Singapore., Wong RX; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore., Nei WL; SingHealth Duke-NUS Oncology Academic Clinical Program, Duke NUS Medical School, Singapore.; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore., Kwek JW; SingHealth Duke-NUS Oncology Academic Clinical Program, Duke NUS Medical School, Singapore.; Division of Oncologic Imaging, National Cancer Centre Singapore, Singapore., Thng CH; Division of Oncologic Imaging, National Cancer Centre Singapore, Singapore., Hennedige T; Division of Oncologic Imaging, National Cancer Centre Singapore, Singapore., Tang PY; Department of Anatomical Pathology, Singapore General Hospital, Singapore.; Duke-NUS Medical School, Singapore., Selvarajan S; Department of Anatomical Pathology, Singapore General Hospital, Singapore., Tay KJ; Division of Surgery and Surgical Oncology, Department of Urology, Singapore General Hospital, Singapore., Abdul MR; From the Division of Surgery and Surgical Oncology, Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), National Cancer Centre Singapore, Singapore.; Division of Surgery and Surgical Oncology, Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Singapore General Hospital, Singapore., Wong JSM; From the Division of Surgery and Surgical Oncology, Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), National Cancer Centre Singapore, Singapore.; Division of Surgery and Surgical Oncology, Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Singapore General Hospital, Singapore.; SingHealth Duke-NUS Oncology Academic Clinical Program, Duke NUS Medical School, Singapore.; SingHealth Duke-NUS Surgery Academic Clinical Program, Duke NUS Medical School, Singapore., Seo CJ; From the Division of Surgery and Surgical Oncology, Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), National Cancer Centre Singapore, Singapore.; Division of Surgery and Surgical Oncology, Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Singapore General Hospital, Singapore.; SingHealth Duke-NUS Oncology Academic Clinical Program, Duke NUS Medical School, Singapore., Soo KC; From the Division of Surgery and Surgical Oncology, Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), National Cancer Centre Singapore, Singapore.; Division of Surgery and Surgical Oncology, Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Singapore General Hospital, Singapore., Chia CS; From the Division of Surgery and Surgical Oncology, Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), National Cancer Centre Singapore, Singapore.; Division of Surgery and Surgical Oncology, Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Singapore General Hospital, Singapore.; SingHealth Duke-NUS Oncology Academic Clinical Program, Duke NUS Medical School, Singapore.; SingHealth Duke-NUS Surgery Academic Clinical Program, Duke NUS Medical School, Singapore., Ong CJ; From the Division of Surgery and Surgical Oncology, Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), National Cancer Centre Singapore, Singapore.; Division of Surgery and Surgical Oncology, Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Singapore General Hospital, Singapore.; Laboratory of Applied Human Genetics, Division of Medical Sciences, National Cancer Centre Singapore, Singapore.; Institute of Molecular and Cell Biology, A*STAR Research Entities, Singapore.; SingHealth Duke-NUS Oncology Academic Clinical Program, Duke NUS Medical School, Singapore.; SingHealth Duke-NUS Surgery Academic Clinical Program, Duke NUS Medical School, Singapore.

Publikováno v: Annals of surgery open : perspectives of surgical history, education, and clinical approaches [Ann Surg Open] 2023 Nov 02; Vol. 4 (4), pp. e339. Date of Electronic Publication: 2023 Nov 02 (Print Publication: 2023).